A carregar...
Drug–drug interactions during antiviral therapy for chronic hepatitis C
The emergence of direct-acting antiviral agents (DAAs) for HCV infection represents a major advance in treatment. The NS3 protease inhibitors, boceprevir and telaprevir, were the first DAAs to receive regulatory approval. When combined with PEG-IFN and ribavirin, these agents increase rates of susta...
Na minha lista:
| Publicado no: | Nat Rev Gastroenterol Hepatol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4634866/ https://ncbi.nlm.nih.gov/pubmed/23817323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrgastro.2013.106 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|